CLOV vs LAB
Clover Health Investments Corp (CLOV) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CLOV currently screens at market cap $1.55B. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CLOV and LAB stock pages for the full models.
Not investment advice.